According to the research report titled ‘Global Proton Therapy Market Analysis By Product (Equipment, Services), By Type (Singe Room, Multi-Room), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)’, available with Market Study Report, global proton therapy market is anticipated to expand with a CAGR of 14.53% during 2018-2023.
 

Growing cases of cancer worldwide, rising medical tourism and increasing number of studies supporting clinical benefits of the treatment are driving the growth of global proton therapy market. Also, widespread adoption of proton therapy among the medical community is impelling the market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1550839/
 

Based on product terrain, global proton therapy market is segmented into proton therapy equipment and proton therapy services.  The report cites that equipment segment is expected to witness momentous growth over the forecast period. With respect to type, the industry is classified into multi-room and single room, wherein the former segment is gaining constant traction.  
 

Speaking of regional landscape, global proton therapy market is segmented into North America, Asia Pacific, Europe, and rest of the world. North America held the largest market share in 2018. Meanwhile, Asia Pacific market is expected to grow rapidly over the forecast period, owing to the presence of large consumer base in developing countries such as China and India, along with increasing per capita expenditure on healthcare.
 

Key players in global proton therapy market include Optivus Proton Therapy Inc., ProTom International, IBA Proton Therapy Inc., ProNova Solutions LLC, Sumitomo Heavy Industries Inc., Advanced Oncotherapy plc, Hitachi Ltd., Varian Medical Systems, and Mevion Medical Systems Inc.